Literature DB >> 16627974

Hypoxic microenvironment as a cradle for melanoma development and progression.

Carmen Z Michaylira1, Hiroshi Nakagawa.   

Abstract

Hypoxia-inducible factor (HIF)-1alpha, a global regulator of oxygen homeostasis, plays a crucial role in tumor cell adaptation to the hypoxic microenvironment through transcriptional regulation of its target genes. These genes in turn are involved in a plethora of biochemical as well as cell biological processes, including glucose metabolism, apoptosis and angiogenesis. In melanoma, HIF-1alpha has been implicated in tumor progression with effects upon metastasis and angiogenesis. However, its role in malignant transformation by oncogenes has not been described. Bedogni et al. (Cancer Cell 2005, 8:443-54) report that the hypoxic microenvironment in the skin contributes to melanocyte transformation and tumor growth induced by oncogenes Ras and Akt, which are frequently activated in melanoma. HIF-1alpha activity was found to be required in Akt-induced melanocyte transformation and tumor growth and it was suppressed greatly by mTOR inhibition with rapamycin. Since mTOR regulates HIF-1alpha expression and its transcriptional activity, rapamycin was proposed as a promising hypoxia-related therapeutic approach in melanoma treatment. This study sheds light upon the role of HIF-1alpha in the early stage of melanoma development and highlights the importance of the Akt-mTOR pathway in the regulation of HIF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627974     DOI: 10.4161/cbt.5.5.2749

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  16 in total

1.  Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Nikolaos E Bechrakis; Gregor Willerding; Georgios St Charitoudis; Michael H Foerster; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Journal:  Clin Exp Metastasis       Date:  2011-10-09       Impact factor: 5.150

2.  HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Authors:  Na-Na Tang; Hong Zhu; Hong-Jie Zhang; Wei-Feng Zhang; Hai-Lin Jin; Lu Wang; Pin Wang; Gui-Jun He; Bo Hao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia.

Authors:  Anna Lisa Furfaro; Giulia Loi; Caterina Ivaldo; Mario Passalacqua; Gabriella Pietra; Giovanni Enrico Mann; Mariapaola Nitti
Journal:  Antioxidants (Basel)       Date:  2022-06-14

4.  Hypoxia induces differential translation of enolase/MBP-1.

Authors:  Kara C Sedoris; Shelia D Thomas; Donald M Miller
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

5.  LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

Authors:  YanHong Yao; HaiTao Wang; BaoGuo Li
Journal:  Tumour Biol       Date:  2014-04-18

6.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

7.  Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth.

Authors:  Yeqiang Liu; Juan Tao; Yan Li; Jing Yang; Yan Yu; Min Wang; Xiaoyuan Xu; Changzheng Huang; Wei Huang; Jing Dong; Li Li; Jing Liu; Guanxin Shen; Yating Tu
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

Review 8.  Angiogenesis in melanoma.

Authors:  Ganapati H Mahabeleshwar; Tatiana V Byzova
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

9.  Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism.

Authors:  Asunción Fernández-Barral; José Luis Orgaz; Valentí Gomez; Luis del Peso; María José Calzada; Benilde Jiménez
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

10.  A bioreactor model of mouse tumor progression.

Authors:  George A Thouas; John Sheridan; Kerry Hourigan
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.